|
WO2021074288A1
|
|
Non-coding rna protecting against heart failure
|
|
EP3809136A1
|
|
Tcr-independent molecular identification of mutation-related and tumor-specific t cells
|
|
EP3771909A1
|
|
Analytical method and immunological treatment for bladder cancer
|
|
EP3760718A1
|
|
Tissue for use as allogeneic or xenogeneic transplant and method for its production
|
|
EP3753566A1
|
|
All-in one viral vector for car and therapeutic effector molecule
|
|
EP3747992A1
|
|
Compositions and process for integrating cells into epithelium
|
|
EP3730153A1
|
|
Personalized immunotherapy for treatment of cancer
|
|
EP3741398A1
|
|
Method for coating a medical device and coated medical device
|
|
EP3733697A1
|
|
Artificial signalling molecule
|
|
CN112189018A
|
|
Chimeric antigen receptor and CAR-T cells that bind to herpes virus antigens
|
|
EP3714944A1
|
|
Car for use in the treatment of hvg disease
|
|
EP3669900A1
|
|
Genetically manipulated cornea for transplantation
|
|
BR112020009532A2
|
|
improved compound for treating heart failure
|
|
WO2019072789A1
|
|
Diagnostics and therapy for human respiratory syncytial virus (hrsv)
|
|
EP3564363A1
|
|
Production of megakaryocytes in bioreactors
|
|
EP3545845A1
|
|
Method for processing computed tomography imaging data of a suspect`s respiratory system
|
|
EP3540046A1
|
|
Process for producing cardiac organoids
|
|
EP3524209A1
|
|
Magnetic artificial joint
|
|
DE102017130526A1
|
|
Needle-shaped applicator
|
|
EP3495114A1
|
|
Method for manufacturing a component and assembly for same
|
